Chemotherapy of small cell lung cancer.

[1]  H. Hansen,et al.  Combination chemotherapy in the management of superior vena caval obstruction in small-cell anaplastic carcinoma of the lung. , 2009, Acta medica Scandinavica.

[2]  D. Ettinger,et al.  A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  H. Earl,et al.  The response of cerebral metastases in small cell lung cancer to systemic chemotherapy. , 1990, British Journal of Cancer.

[4]  K. Østerlind.  Alternating or sequential chemotherapy in small cell lung cancer , 1989 .

[5]  M. Fukuoka,et al.  Chemotherapy in small cell lung cancer: a consensus report , 1989 .

[6]  G. Giaccone.  Second line chemotherapy in small cell lung cancer , 1989 .

[7]  K. Propert,et al.  A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  W. Murphy,et al.  Primary chemotherapy of brain metastasis in small-cell lung cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. Postmus,et al.  High-dose etoposide for meningeal carcinomatosis in patients with small cell lung cancer. , 1989, European journal of cancer & clinical oncology.

[10]  J. Lagrange,et al.  Brain metastases of lung cancer: excessive toxicity of high dose VP 16 213. , 1988, European journal of cancer & clinical oncology.

[11]  R. Steele,et al.  Histopathologic classification of small cell lung cancer changing concepts and terminology , 1988, Cancer.

[12]  G. Giaccone,et al.  Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung. , 1988, European Journal of Cancer and Clinical Oncology.

[13]  H. Hansen,et al.  Brain metastases from small cell lung cancer treated with combination chemotherapy. , 1988, European journal of cancer & clinical oncology.

[14]  H. Hansen,et al.  The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay. , 1988, European journal of cancer & clinical oncology.

[15]  D. Crowther,et al.  Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. , 1987, British Journal of Cancer.

[16]  D. Osoba,et al.  Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Mountain.  Staging of lung cancer: The new international system , 1987 .

[18]  F. Hirsch,et al.  The superiority of combination chemotherapy including etoposide based on in vivo cell cycle analysis in the treatment of extensive small-cell lung cancer: a randomized trial of 288 consecutive patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  H. Hansen.  Chemotherapy of small cell carcinoma: a review. , 1987, The Quarterly journal of medicine.

[20]  J. Sculier,et al.  Intensive chemotherapy in small cell lung cancer. , 1986, European journal of cancer & clinical oncology.

[21]  P. Bunn,et al.  Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  F. Greco,et al.  Randomized dose-response evaluation of etoposide in small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial. , 1986, Cancer treatment reports.

[23]  J. Pedersen‐Bjergaard,et al.  Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung , 1985 .

[24]  R. James,et al.  Three months' treatment with cyclophosphamide, VP‐16‐213 followed by methotrexate and thoracic radiotherapy for small cell lung cancer , 1985, Cancer.

[25]  N. Thatcher,et al.  Three months treatment with chemotherapy and radiotherapy for small cell lung cancer. , 1985, British Journal of Cancer.

[26]  B. Kramer,et al.  Effects of intravenous hyperalimentation during treatment in patients with small-cell lung cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  R. Souhami,et al.  High-dose cyclophosphamide in small-cell carcinoma of the lung. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Mckneally,et al.  Intensive induction chemotherapy for small cell anaplastic carcinoma of the lung. , 1985, Cancer treatment reports.

[29]  H. Muss,et al.  VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D. Gandara,et al.  Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  H. Hansen,et al.  Cyclic alternating 'non-cross resistant' chemotherapy in the management of small cell anaplastic carcinoma of the lung. , 1984, Cancer Treatment Reviews.

[32]  H. Kantarjian,et al.  Systemic Combination Chemotherapy as Primary Treatment of Brain Metastasis From Lung Cancer , 1984, Southern medical journal.

[33]  W. Henderson,et al.  Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. , 1981, JAMA.

[34]  R. Makuch,et al.  Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival. , 1980, Journal of the National Cancer Institute.

[35]  F. Hirsch,et al.  Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. , 1980, Cancer research.

[36]  J. Minna,et al.  Intensive chemotherapy of small cell bronchogenic carcinoma. , 1977, Cancer treatment reports.

[37]  R. Kane,et al.  Superior vena caval obstruction due to small-cell anaplastic lung carcinoma. Response to chemotherapy. , 1976, JAMA.

[38]  M. Chasen,et al.  Prognostic factors in small-cell carcinoma , 1986 .

[39]  M. Spang‐Thomsen,et al.  Limitations and Potentials of In Vitro Sensitivity Testing of Human Small Cell Carcinoma of the Lung , 1986 .

[40]  W. Hryniuk,et al.  Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  D. Osoba,et al.  Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  D. Ettinger,et al.  Staging and prognostic factors in small cell carcinoma of the lung. , 1983, Cancer treatment reports.

[43]  J H Goldie,et al.  Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982, Cancer treatment reports.